Source: Sleep and Breathing Conference 2017



Rating:

Share or cite this content

Citations should be made in the following way:
Peter J. Wijkstra (Groningen, Netherlands). Positional therapy: easy and effective?. Sleep and Breathing Conference 2017

Member's Comments

No comment yet.

Related content which might interest you: Positional therapy: who, when and how? Source: Sleep and Breathing Conference 2021 Year: 2021 Four-month regimens: are they feasible? Source: International Congress 2015 – Tuberculosis: short-course chemotherapy Year: 2015 Rapid, reliable and responsive: for whom? Source: Eur Respir J 2004; 23: 1-2 Year: 2004 Inhaled antibiotics: a new tool? Source: Annual Congress 2009 - Antibiotics and the lung Year: 2009 Steroids related tuberculosis: Does a subgroup require a more cautious approach? Source: Annual Congress 2011 - Clinical tuberculosis Year: 2011 What makes a team effective? Source: Virtual Congress 2020 – Teamability: becoming an effective team leader and member Year: 2020 Do we have any alternative therapeutic option beyond antibiotics? Source: Postgraduate course 2021: PG7 - Postgraduate course : Emerging infectious diseases and antimicrobial resistance: diagnostics, treatments, vaccines and other preventive and/or therapeutic interventions Year: 2021 Pharmacological treatment optimisation for stable COPD: an endless story? Source: Eur Respir J, 50 (4) 1701250; 10.1183/13993003.01250-2017 Year: 2017 Evaluating disease-modifying treatment in CF: are we ready to take the challenge? Source: International Congress 2014 – Ceremony for the ERS Rare Pulmonary Disease Research Award 2014 followed by the symposium "Challenges in endpoints for rare lung diseases" Year: 2014 Investigating the steroids and long-acting β2-agonists combination: why do we need more? Source: Eur Respir J 2004; 23: 501-502 Year: 2004 Late Breaking Abstract - Was our step-down virtual covid ward safe and effective? Source: Virtual Congress 2021 – Nursing perspective during the COVID-19 pandemic Year: 2021 Introducing a new formulation of pirfenidone to reduce tablet burden for the IPF patient: Is it tolerable? Is it easy to take? What do our patients think? Source: International Congress 2018 – Management of idiopathic interstitial pneumonias: established and new treatments Year: 2018 Biodiesel: is it any safer to use? Source: International Congress 2018 – Occupational and environmental lung diseases: mechanisms, biomarkers and causation Year: 2018 Second-line injectables: are they essential to treat MDR/XDR-TB cases? Source: Annual Congress 2008 - Multidrug-resistant and the emerging threat of extensively drug-resistant tuberculosis Year: 2008 Halotherapy and Covid-19: an oppinion for a possible future prevention approach Source: Virtual Congress 2021 – COVID – 19: treatments and predictive factors Year: 2021